[1] Oselin K, Girard N, Lepik K, et al.  Pathological discrepancies in the diagnosis of thymic epithelial tumors: the Tallinn-Lyon experience[J]. J Thorac Dis, 2019, 11(2): 456-464.   doi: 10.21037/jtd.2018.12.123
[2] Marx A, Chan JKC, Coindre JM, et al.  The 2015 World Health Organization classification of tumors of the thymus: continuity and changes[J]. J Thorac Oncol, 2015, 10(10): 1383-1395.   doi: 10.1097/JTO.0000000000000654
[3] Ishibashi M, Tanabe Y, Yunaga H, et al.  Usefulness of preoperative 18F-FDG PET/CT for patients with thymic epithelial tumors[J]. Yonago Acta Med, 2019, 62(1): 146-152.   doi: 10.33160/yam.2019.03.020
[4] 高珂梦, 丁重阳, 孙晋, 等.  原发性肺黏膜相关淋巴组织淋巴瘤的18F-FDG PET/CT影像学表现[J]. 国际放射医学核医学杂志, 2019, 43(2): 140-144.   doi: 10.3760/cma.j.issn.1673-4114.2019.02.008
Gao KM, Ding CY, Sun J, et al.  18F-FDG PET/CT manifestation of primary pulmonary mucosa-associated lymphoid tissue lymphoma[J]. Int J Radiat Med Nucl Med, 2019, 43(2): 140-144.   doi: 10.3760/cma.j.issn.1673-4114.2019.02.008
[5] 丁辉, 胡传贤, 黄苏, 等.  基于CT和18F-FDG PET/CT的肺癌风险预测模型对肺结节恶性风险的验证研究[J]. 国际放射医学核医学杂志, 2019, 43(1): 17-21.   doi: 10.3760/cma.j.issn.1673-4114.2019.01.004
Ding H, Hu CX, Huang S, et al.  Verification of malignant risk of pulmonary nodules based on CT and 18F-FDG PET/CT prediction model[J]. Int J Radiat Med Nucl Med, 2019, 43(1): 17-21.   doi: 10.3760/cma.j.issn.1673-4114.2019.01.004
[6] Lococo F.  The role of 18F-FDG PET/CT scan in predicting histological type of thymic epithelial tumors: indications and practical clinical considerations[J]. Thorac Cardiovasc Surg, 2018, 66(4): 350-351.   doi: 10.1055/s-0037-1604209
[7] Lee HS, Oh JS, Park YS, et al.  Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via 18F-FDG PET/CT[J]. Ann Nucl Med, 2016, 30(4): 309-319.   doi: 10.1007/s12149-016-1062-2
[8] Eguchi T, Yoshida K, Hamanaka K, et al.  Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours[J]. Eur J Cardiothorac Surg, 2012, 41(5): 1059-1062.   doi: 10.1093/ejcts/ezr144
[9] Fukumoto K, Taniguchi T, Ishikawa Y, et al.  The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours[J]. Eur J Cardiothorac Surg, 2012, 42(6): e152-e156.   doi: 10.1093/ejcts/ezs527
[10] Park SY, Cho A, Bae MK, et al.  Value of 18F-FDG PET/CT for predicting the World Health Organization malignant grade of thymic epithelial tumors: focused in volume-dependent parameters[J]. Clin Nucl Med, 2016, 41(1): 15-20.   doi: 10.1097/RLU.0000000000001032
[11] Gong J, Jin S, Pan X, et al.  Identification of long non-coding RNAs for predicting prognosis among patients with thymoma[J]. Clin Lab, 2018, 64(7): 1193-1198.   doi: 10.7754/Clin.Lab.2018.180136
[12] Tomita M, Ayabe T, Tsuchiya K, et al.  Fluorodeoxyglucose positron emission tomography can provide useful information for differentiating thymic epithelial tumors[J]. Thorac Cardiovasc Surg, 2018, 66(4): 345-349.   doi: 10.1055/s-0037-1604208